Akut mieloid leukémia (AML): vizsgálatok itt: Brazília
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Barretos, Brasília, Curitiba, Natal, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
- Where
- Curicica, Florianópolis, São Paulo
- Életkor
- 18 év to 75 év
- People
- 366 worldwide
- Run by
- Priothera SAS
See details and how to joinNCT05429632 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Barretos, Fortaleza, Jaú, Porto Alegre, São Paulo
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 2. fázisTaking peopleEvaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Where
- Curitiba, Minas Gerai, Porto Alegre, Rio de Janeiro, San Jose Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06824168 - 2. fázisTaking peopleOral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
- Where
- São Paulo
- Életkor
- 18 év to 75 év
- People
- 115
- Run by
- Instituto do Cancer do Estado de São Paulo
See details and how to joinNCT06982274 - 1/2. fázisTaking peoplePTCy and ATG for MSD and MUD Transplants
- Where
- Rio de Janeiro
- Életkor
- 18 év to 60 év
- People
- 50
- Run by
- Instituto Nacional de Cancer, Brazil
See details and how to joinNCT06299462 - 2. fázisNot yet taking people in BrazíliaNK Cell Infusion for Remission Consolidation in AML: A Phase II Trial
- Where
- Porto Alegre
- Életkor
- 18 év to 75 év
- People
- 98
- Run by
- Hospital de Clinicas de Porto Alegre
See details and how to joinNCT06783478 - 2. fázisTaking peopleSafety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
- Where
- Belém, Curitiba, Florianópolis, Jaú, Joinville
- Életkor
- 18 év and over
- People
- 100
- Run by
- Hospital Municipal São José
See details and how to joinNCT06537843